TRACEY KOLUND: Open Payments
NPI 1992024400 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$272 in 12 payments from 7 companies in 2025. Trend: 2023 $321 · 2024 $714 · 2025 $272
Food & beverage: $272
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $71 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Eisai Inc. | 2 | $37 |
| Fennec Pharmaceuticals, Inc. | 1 | $34 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| PFIZER INC. | 1 | $21 |
Products named: ELAHERE, KEYTRUDA, LYNPARZA, Lenvima, Fyarro, JEMPERLI, TIVDAK.
Industry payments across NE — which companies pay providers there.
